Citation Impact
Citing Papers
Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity?
2008
Ageing populations: the challenges ahead
2009 Standout
Long-term depression versus episodic major depression: Results from the prospective Zurich study of a community sample
2008
Depression
2018 Standout
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
No health without mental health
2007 Standout
Inflammation and Alzheimer's disease
2000 Standout
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial
2002
mTOR Signaling in Growth Control and Disease
2012 Standout
Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity.
1997 Standout
Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial
2003
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
2009
From Molecular Structure to Alzheimer Therapy.
1997
Antecedent- and response-focused emotion regulation: Divergent consequences for experience, expression, and physiology.
1998 Standout
Vascular dementia
2015 Standout
A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle
2017
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
2011 Standout
Alzheimer’s Disease – The Importance of Early Detection
2008
Resources for mental health: scarcity, inequity, and inefficiency
2007 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period
2005
Mixed Dementia
2004
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Sarcopenia: characteristics, mechanisms and functional significance
2010
The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia
2003
The Alzheimer's Disease Assessment Scale: Evaluation of Psychometric Properties and Patterns of Cognitive Decline in Multicenter Clinical Trials of Mild to Moderate Alzheimer's Disease
2001
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
New Approaches to Clinical Trials in Vascular Dementia: Memantine in Small Vessel Disease
2002
Skeletal muscle dysfunction in critical care: Wasting, weakness, and rehabilitation strategies
2010
ApoE genotype accounts for the vast majority of AD risk and AD pathology
2004
Reflex control of immunity
2009 Standout
Down Syndrome: Advances in Molecular Biology and the Neurosciences
2001
Disuse of the musculo-skeletal system in space and on earth
2010
Alzheimer's disease
2006 Standout
Release of reactive oxygen and nitrogen intermediates from monocytes of patients with pulmonary tuberculosis
1995
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>
1998
Mental health of young people: a global public-health challenge
2007 Standout
Chapter 9 The central cholinergic system during aging
1994
Exercise Metabolism and the Molecular Regulation of Skeletal Muscle Adaptation
2013
A case‐control study of Alzheimer's disease
1990
Rivastigmine in subcortical vascular dementia
2002
AKT/PKB Signaling: Navigating the Network
2017 Standout
Risk of dementia in diabetes mellitus: a systematic review
2005 Standout
Down's syndrome
2003 Standout
Alzheimer's Disease
2004 Standout
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Recent developments in natural product synthesis using metal-catalysed C–H bond functionalisation
2011 Standout
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
1996 Standout
Estrogen Actions in the Central Nervous System1
1999 Standout
The Lycopodium alkaloids
2004 Standout
Estrogen and Basal Forebrain Cholinergic Neurons: Implications for Brain Aging and Alzheimer's Disease-Related Cognitive Decline
1998
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Biological effects of essential oils – A review
2007 Standout
Hearing Loss and Cognitive Decline in Older Adults
2013 Standout
Prevalence and Incidence Studies of Anxiety Disorders: A Systematic Review of the Literature
2006
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Are Alzheimer Patients Healthier?
1988
Poverty and common mental disorders in developing countries.
2003
Constituents from Salvia Species and Their Biological Activities
2012 Standout
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study
2008
Signals mediating skeletal muscle remodeling by resistance exercise: PI3-kinase independent activation of mTORC1
2010
Invited Review Cholinesterase inhibitors for Alzheimer’s disease therapy: from tacrine to future applications
1998
The role of mTOR signaling in the regulation of protein synthesis and muscle mass during immobilization in mice
2015
Disorders of Emotion
1991
Rivastigmine in subcortical vascular dementia: A randomized, controlled, open 12-month study in 208 patients
2003
A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease
1997 Standout
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Bright Side of Lignin Depolymerization: Toward New Platform Chemicals
2018 Standout
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
1998
Navigating from hippocampus to parietal cortex
2008 StandoutNobel
A Clinical Overview of Cholinesterase Inhibitors in Alzheimer’s Disease
2002
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
2004 Standout
Physiological adaptations to interval training and the role of exercise intensity
2016 Standout
P2Y1 and Cysteinyl Leukotriene Receptors Mediate Purine and Cysteinyl Leukotriene Co-Release in Primary Cultures of Rat Microglia
2005
Use of Cholinesterase Inhibitors in Clinical Practice: Evidence-Based Recommendations
2003
Influence of aerobic exercise intensity on myofibrillar and mitochondrial protein synthesis in young men during early and late postexercise recovery
2014
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: Common links and potential therapeutic targets
2004
The Proprioceptive Senses: Their Roles in Signaling Body Shape, Body Position and Movement, and Muscle Force
2012 Standout
Diabetes mellitus and the risk of dementia
1999 Standout
Efficient Total Synthesis of Novel Bioactive Microbial Metabolites
2008 StandoutNobel
Ribosome Biogenesis: Emerging Evidence for a Central Role in the Regulation of Skeletal Muscle Mass
2014 Standout
From Molecular Structure to Alzheimer Therapy
1997
Cholinesterase inhibitors for Alzheimer's disease
2006 Standout
Physiology of Microglia
2011 Standout
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
2007 Standout
Works of Vinod Kumar being referenced
Age‐related differences in the dose–response relationship of muscle protein synthesis to resistance exercise in young and old men
2008
An efficacy and safety analysis of Exelon® in Alzheimer’s disease patients with concurrent vascular risk factors
2000
Rivastigmine for Alzheimer's Disease
2000
Facts, noise and wishful thinking: muscle protein turnover in aging and human disuse atrophy
2010
CSF choline and acetylcholinesterase in early-onset vs. late-onset Alzheimer's disease patients
1989
Role of oxygen free radicals generated by blood monocytes and neutrophils in the pathogenesis of rheumatic fever and rheumatic heart disease
1990
New Anti-inflammatory Treatment Strategy in Alzheimer’s Disease
2000
Treatment of Alzheimer's disease with cholinergic drugs.
1991
Advances in the Diagnosis and Treatment of Alzheimer's Disease
2000
Effects of metrifonate, a long‐acting cholinesterease inhibitor, in alzheimer disease: Report of an open trial
1990
Crosstalk of EDA-A2/XEDAR in the p53 Signaling Pathway
2010
Thyroid Disease in Patients With Dementia of the Alzheimer Type
1985
Alzheimer disease assessment scale: useful for both early detection and staging of dementia of the Alzheimer type.
1992
A community survey
1988
Update on the Development of Medication for Memory and Cognition in Alzheimer's Disease
1996